MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Journal of Medicinal Chemistry
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

762 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
762 works in the cohort · of 4,299,418page 5 of 16

Labels cover 4 of 762 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 762 of 762 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Discovery of 1-{4-[3-Fluoro-4-((3 <i>S</i> ,6 <i>R</i> )-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist
Benjamin P. Fauber, Olivier René, Yuzhong Deng, Jason DeVoss, Céline Eidenschenk, Christine Everett +11 more
2015· article· en· Journal of Medicinal Chemistry· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
59
citations
afffundunlabeled
(<i>S</i>)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class I PI3K and mTOR Kinase
Denise Rageot, Thomas Bohnacker, Erhan Keleş, Jacob A. McPhail, Reece M. Hoffmann, Anna Melone +9 more
2019· article· en· Journal of Medicinal Chemistry· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
55
citations
afffundunlabeled
Heat Shock Protein 70 Inhibitors. 2. 2,5′-Thiodipyrimidines, 5-(Phenylthio)pyrimidines, 2-(Pyridin-3-ylthio)pyrimidines, and 3-(Phenylthio)pyridines as Reversible Binders to an Allosteric Site on Heat Shock Protein 70
Tony Taldone, Yanlong Kang, Hardik J. Patel, Maulik Patel, Pallav D. Patel, Anna Rodina +7 more
2014· article· en· Journal of Medicinal Chemistry· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · metaepi_narrow
55
citations
fundno affunlabeled
Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis
Vassilios Myrianthopoulos, Nicolas Gaboriaud‐Kolar, C. Tallant, Michelle-Lynn Hall, Stylianos Grigoriou, Peter M. Brownlee +16 more
2016· article· en· Journal of Medicinal Chemistry· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
50
citations

How this was built: Screen · Findings · About